Lars Gullestad

28.0k citations
463 papers · 17.6k · 3 hit papers · h-index 65

Impact in

Papers in

    • Viral Infections and Immunology Research 32
    • Cardiac Fibrosis and Remodeling 31
    • Heart Failure Treatment and Management 22
    • Cardiovascular Function and Risk Factors 21
    • Cardiac Valve Diseases and Treatments 19
    • Transplantation: Methods and Outcomes 92

Lars Gullestad

451 papers receiving 17.2k citations

Lars Gullestad's Hit Papers

Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial 2016 · 295 citations
2950+4+8Years since publication100200300400500

Peers

Lars Gullestad
Comparison fields: 5 of 163
  • Cardiology and Cardiovascular Medicine 6.3k
  • Transplantation 498
  • Immunology 2.4k
  • Surgery 3.1k
  • Complementary and alternative medicine 601
Replace Marta Ruiz‐Ortega with:
Marta Ruiz‐Ortega Spain
Hermann Haller Germany
Juan J. Badimón United States
Douglas E. Vaughan United States
Ariela Benigni Italy
P. Christian Schulze Germany
François Mach Switzerland
Howard J. Eisen United States
Ron C. Hoogeveen United States
Antonio Abbate United States
Lars Gullestad relative to Marta Ruiz‐Ortega Spain Marta Ruiz‐Ortega's profile →
Citations per field
00.5×4.5×
Marta Ruiz‐Ortega · 1×
Citations per year

Countries citing papers authored by Lars Gullestad

Since Specialization
Citations

This map shows the geographic impact of Lars Gullestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gullestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gullestad more than expected).

Fields of papers citing papers by Lars Gullestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Gullestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gullestad. The network helps show where Lars Gullestad may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars Gullestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars Gullestad Line = papers co-authored together Lars Gullestad links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 463 papers — load more, or switch the sort, to bring in the rest.

#Work
1
EUR Observational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Hit paper breakdown →
2013593
2 1999413
3 2007405
4 1999369
5 2014367
6 1998311
7 2010299
8
Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
Hit paper breakdown →
2016295
9 2012278
10
Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial
Hit paper breakdown →
2016278
11 2001274
12 2006241
13 2009237
14 2005198
15 2010187
16 2013177
17 2009168
18 2004161
19 2006157
20 1997156

About Lars Gullestad

Lars Gullestad is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Immunology and Oncology, having authored 463 papers that have together received 17.6k indexed citations. Recurring topics across this work include Transplantation: Methods and Outcomes (92 papers), Viral Infections and Immunology Research (32 papers), Cardiac Fibrosis and Remodeling (31 papers), Heart Failure Treatment and Management (22 papers), Cardiovascular Function and Risk Factors (21 papers), Atherosclerosis and Cardiovascular Diseases (21 papers), Cardiac Valve Diseases and Treatments (19 papers) and Renal Transplantation Outcomes and Treatments (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.3k citations), Transplantation (498 citations), Immunology (2.4k citations), Surgery (3.1k citations) and Complementary and alternative medicine (601 citations). Lars Gullestad has collaborated with scholars based in Norway, Sweden and United States. Frequent co-authors include Thor Ueland, Pål Aukrust, Arne Yndestad, Stig S. Frøland, Pål Aukrust, Jan Kristian Damås, John Kjekshus, Svein Simonsen, Erik Øie and Bente Halvorsen. Their work appears in journals such as The Journal of Heart and Lung Transplantation, Circulation, Clinical Transplantation, European Journal of Heart Failure and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact